These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7788734)

  • 21. [Experimental studies on inhibitory effects of radix Peucedani on hypoxic pulmonary hypertension in rats].
    Xi SC; Ruan YM; Zhang LZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Apr; 16(4):218-20. PubMed ID: 9206245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.
    Ahmed LA; Obaid AA; Zaki HF; Agha AM
    Eur J Pharm Sci; 2014 Oct; 62():161-70. PubMed ID: 24878387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats.
    Vieillard-Baron A; Frisdal E; Raffestin B; Baker AH; Eddahibi S; Adnot S; D'Ortho MP
    Hum Gene Ther; 2003 Jun; 14(9):861-9. PubMed ID: 12828857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study.
    Jones R; Zapol WM; Reid L
    Am J Pathol; 1984 Nov; 117(2):273-85. PubMed ID: 6238536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of pulmonary artery protein kinase C activity in rats with chronic inflammatory pulmonary hypertension].
    Dong X; Wang G; Wang HL; Zhang XH; Zong ZH; Xing J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):875-7. PubMed ID: 17584659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of tetrandrine on pulmonary hypertension induced by monocrotaline in rats].
    Zhang S; Sun B; Zhang J; Li F; Lei S; Cheng D; Yang X; Tan Y; Yao X; Li T
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):378-80. PubMed ID: 8732055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
    Luan Y; Chao S; Ju ZY; Wang J; Xue X; Qi TG; Cheng GH; Kong F
    Int Immunopharmacol; 2015 May; 26(1):188-93. PubMed ID: 25601497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
    Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Rocha Nde N; Ferraz EB; do Nascimento JH; Sudo RT; Zapata-Sudo G
    Eur J Pharmacol; 2013 Feb; 702(1-3):316-22. PubMed ID: 23399770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relation of intra-acinar arteries and their regression with changes of pulmonary artery pressure and blood gas values].
    Sun BT
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):130-3, 188. PubMed ID: 1913955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and pathological implication of transforming growth factor-beta1 mRNA and endothelin-1 mRNA in intraacinar pulmonary arterioles of congenital heart disease accompanied with pulmonary hypertension].
    Gao BH; Yao RX; Zhao ZG; Xie LW; Xiang RL; Hu XT; Wang ZM
    Zhonghua Bing Li Xue Za Zhi; 2005 Mar; 34(3):159-62. PubMed ID: 15938827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats.
    Wang HL; Dong X; Zhang XH; Xing J
    Acta Pharmacol Sin; 2001 Mar; 22(3):269-73. PubMed ID: 11742576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monocrotaline-induced pulmonary hypertension in animals].
    Tanino Y
    Nihon Rinsho; 2001 Jun; 59(6):1076-80. PubMed ID: 11411116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.